RWIBX
Price
$64.43
Change
-$4.56 (-6.61%)
Updated
Dec 17 closing price
RWIEX
Price
$65.25
Change
-$4.68 (-6.69%)
Updated
Dec 17 closing price
Ad is loading...

RWIBX vs RWIEX

Header iconRWIBX vs RWIEX Comparison
Open Charts RWIBX vs RWIEXBanner chart's image
American Funds Capital World Gr&Inc R2
Price$64.43
Change-$4.56 (-6.61%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R4
Price$65.25
Change-$4.68 (-6.69%)
VolumeN/A
CapitalizationN/A
RWIBX vs RWIEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RWIBX vs. RWIEX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RWIBX is a Buy and RWIEX is a Buy.

FUNDAMENTALS
Fundamentals
RWIBX (130B) and RWIEX (130B) have equal amount of cash in the bank . RWIEX pays higher dividends than RWIBX: RWIEX (1.68) vs RWIBX (1.05). RWIBX was incepted earlier than RWIEX: RWIBX (23 years) vs RWIEX (22 years). RWIBX (27.00) and RWIEX (27.00) have comparable annual turnover. RWIBX (250) and RWIEX (250) have matching initial minimum investment requirements. RWIEX annual gain was more profitable for investors over the last year : 12.05 vs. RWIBX (11.34). RWIEX return over 5 years is better than : 32.50 vs. RWIBX (29.64).
RWIBXRWIEXRWIBX / RWIEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years22 years-
Gain YTD9.78110.46493%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets130B130B100%
Annual Yield % from dividends1.051.6862%
Returns for 1 year11.3412.0594%
Returns for 3 years8.419.9684%
Returns for 5 years29.6432.5091%
Returns for 10 years44.2247.7793%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LITM0.180.03
+17.46%
Snow Lake Resources Ltd
NUVB2.810.12
+4.46%
Nuvation Bio
ENTG109.362.65
+2.48%
Entegris
ARQ7.01-0.04
-0.57%
Arq
PTCT47.02-1.59
-3.27%
PTC Therapeutics